SNG.L Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 11:29):

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease...

Stats
Today's Volume	330 487
Average Volume	424 029
Market Cap	13.59M
EPS	£0 ( 2023-09-21 )
Next earnings date	( £0 ) 2024-04-25
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-1.350
ATR14	£0.445 (6.14%)

Synairgen PLC Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Synairgen PLC Financials

Annual	2022
Revenue:	£0
Gross Profit:	£-102 000 (0.00 %)
EPS:	£-0.0876

Q2	2023
Revenue:	£0
Gross Profit:	£-50 000.00 (0.00 %)
EPS:	£-0.0236

Q4	2022
Revenue:	£0
Gross Profit:	£-50 000.00 (0.00 %)
EPS:	£-0.0260

Q2	2022
Revenue:	£0
Gross Profit:	£-52 000.00 (0.00 %)
EPS:	£-0.0616

Financial Reports:

No articles found.

Synairgen PLC